Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...
The National Institute for Health and Care Excellence (NICE) has approved a one-off gene editing therapy to treat severe sickle cell disease (SCD) in people 12 years and over. In final draft guidance1 ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
NHS officials estimate around 50 people a year will receive treatment now it has been approved for use for certain patients with severe sickle cell disease. | ITV National News ...
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...
NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...